Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell Tumors.

Autor: Baky FJ; Memorial Sloan Kettering Cancer Center, Urology Service, Department of Surgery, New York, NY., Liso N; Memorial Sloan Kettering Cancer Center, Urology Service, Department of Surgery, New York, NY., Williams B; Memorial Sloan Kettering Cancer Center, Urology Service, Department of Surgery, New York, NY., Reuter VE; Memorial Sloan Kettering Cancer Center, Department of Pathology & Laboratory Medicine, New York, NY; Weill Cornell Medical College, Department of Pathology and Laboratory Medicine, New York, NY., Tickoo SK; Memorial Sloan Kettering Cancer Center, Department of Pathology & Laboratory Medicine, New York, NY., Feldman DR; Memorial Sloan Kettering Cancer Center, Genitourinary Oncology Service, Department of Medicine, New York, NY; Weill Cornell Medical College, Department of Medicine, New York, NY., Funt SA; Memorial Sloan Kettering Cancer Center, Genitourinary Oncology Service, Department of Medicine, New York, NY; Weill Cornell Medical College, Department of Medicine, New York, NY., Carver BS; Memorial Sloan Kettering Cancer Center, Urology Service, Department of Surgery, New York, NY; Weill Cornell Medical College, Department of Urology, New York, NY., Sheinfeld J; Memorial Sloan Kettering Cancer Center, Urology Service, Department of Surgery, New York, NY; Weill Cornell Medical College, Department of Urology, New York, NY., Matulewicz RS; Memorial Sloan Kettering Cancer Center, Urology Service, Department of Surgery, New York, NY; Weill Cornell Medical College, Department of Urology, New York, NY. Electronic address: matulewr@mskcc.org.

Publikováno v: Urology [Urology] 2024 Nov; Vol. 193, pp. 174-179. Date of Electronic Publication: 2024 Aug 10.

Increased tobacco taxation associated with decreased consumption and bladder cancer incidence.

Autor: Wong R; Dr Kiran C Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, Florida., Matulewicz RS; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York., Talwar R; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Population Health, Vanderbilt University Medical Center, Nashville, Tennessee., Shoenbill KA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Family Medicine, University of North Carolina at Chapel Hill, North Carolina.; Program on Health and Clinical Informatics, University of North Carolina at Chapel Hill, North Carolina., Goldstein AO; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Family Medicine, University of North Carolina at Chapel Hill, North Carolina., Bjurlin MA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publikováno v: Urology practice [Urol Pract] 2024 Oct 25, pp. 101097UPJ0000000000000743. Date of Electronic Publication: 2024 Oct 25.

Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses.

Autor: Matulewicz RS; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Baky F; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knezevic A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sheinfeld J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Williams BM; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kantor RE; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liso N; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hossain J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bromberg M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Valentino A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., So R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Funt SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ye F; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publikováno v: European urology open science [Eur Urol Open Sci] 2024 Aug 17; Vol. 68, pp. 1-9. Date of Electronic Publication: 2024 Aug 17 (Print Publication: 2024).

MicroRNA for Prediction of Teratoma and Viable Germ Cell Tumor after Chemotherapy.

Autor: Baky FJ; Department of Urology, Memorial Sloan Kettering Cancer Center, 430 East 67th Street, New York, NY 10065, USA., Matulewicz RS; Department of Urology, Memorial Sloan Kettering Cancer Center, 430 East 67th Street, New York, NY 10065, USA., Feldman DR; Germ Cell Cancer, Department of Medicine, Memorial Sloan Kettering Cancer Center, 430 East 67th Street, New York, NY 10065, USA., Hamilton RJ; Division of Urology, Princess Margaret Hospital, 3-130, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada., Bagrodia A; Department of Urology, UC San Diego Health, 9400 Campus Point Drive, Suite 1-200, La Jolla, CA 92037, USA. Electronic address: bagrodia@health.ucsd.edu.

Publikováno v: The Urologic clinics of North America [Urol Clin North Am] 2024 Aug; Vol. 51 (3), pp. 387-394. Date of Electronic Publication: 2024 Apr 16.

Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health-Related Quality of Life Measures: An Assessment of the Comparative Effectiveness and Survivorship Health in Bladder Cancer (CEASE-BC) Study.

Autor: Kay H; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Silver SN; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Smith AB; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Basak R; Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Shoenbill K; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Usinger D; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Goldstein AO; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Matulewicz RS; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York., Chen R; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas., Bjurlin MA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publikováno v: The Journal of urology [J Urol] 2024 Jul; Vol. 212 (1), pp. 87-94. Date of Electronic Publication: 2024 Apr 11.